Jump Financial, LLC Y M Abs Therapeutics, Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	SELL	$4.86 - $7.23 $101,510 - $151,013	-20,887 Reduced 52.63%	18,800 $102,000
Q3 2023 Nov 07, 2023	SELL	$4.86 - $7.23 $101,510 - $151,013	-20,887 Reduced 52.63%	18,800 $102,000
Q2 2023 Oct 21, 2024	SELL	$5.68 - $10.34 $6,889 - $12,542	-1,213 Reduced 2.97%	39,687 $269,000
Q2 2023 Aug 07, 2023	SELL	$5.68 - $10.34 $6,889 - $12,542	-1,213 Reduced 2.97%	39,687 $269,000
Q1 2023 Oct 21, 2024	BUY	$2.83 - $5.11 $115,747 - $208,999	40,900 New	40,900 $204,000
Q1 2023 May 03, 2023	BUY	$2.83 - $5.11 $115,747 - $208,999	40,900 New	40,900 $204,000
Q2 2021 Aug 13, 2021	SELL	$25.45 - $37.64 $300,310 - $444,152	-11,800 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $215,171 - $383,412	7,379 Added 166.91%	11,800 $357,000
Q4 2020 Feb 12, 2021	BUY	$37.86 - $54.26 $167,379 - $239,883	4,421 New	4,421 $219,000

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.